PHARMALEX NORWAY AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−329k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−3,8 mill kr).
- Nylig endring 2026-06-03 Adresseendring registrert 2026-06-03.
PHARMALEX NORWAY AS is registered as a limited company in Oslo, Oslo with organisation number 887079862. The business is classified under all other professional, scientific and technical activities n.e.c. (NACE 74.990). The company was incorporated in 2004 and has 13 registered employees. Registered share capital is NOK 100,000, divided into 1000 shares. The company's stated purpose is: “Salg av kunnskapsbaserte tjenester og produkter innenfor helsesektoren og beslektede områder, medvirke i andre selskaper innen samme virksomhet, samt alt som hører naturlig til dette. ”. The most recent filed accounts, for the 2025 financial year, show NOK 20.6m in revenue and NOK −3.8m in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns PHARMALEX NORWAY AS?
PHARMALEX NORWAY AS has 1 registered shareholder:
- PHARMALEX NORDIC APS 100.0%
Group structure
PHARMALEX NORWAY AS er morselskap for 1 datterselskap:
- PHARMALEX NORWAY AS 100%
Frequently asked questions about PHARMALEX NORWAY AS
Who owns PHARMALEX NORWAY AS?
PHARMALEX NORDIC APS is the largest registered owner, with 100.0%.
What is the revenue of PHARMALEX NORWAY AS?
PHARMALEX NORWAY AS had revenue of NOK 20.6m in 2025.
Who is the general manager of PHARMALEX NORWAY AS?
Hege Rønning is registered as general manager of PHARMALEX NORWAY AS.
Where is PHARMALEX NORWAY AS based?
PHARMALEX NORWAY AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.